Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 27, 2020
Augmented teicoplanin clearance through probable adsorption onto a polymethyl methacrylate (PMMA) hemofilter during continuous venovenous hemodiafiltrationKazutaka Oda, Hirofumi Jono, Katsuyuki Sagishima, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 5, 2024
Investigating the WHO's AWaRe classification for assessing antimicrobial stewardship programs: A single-center studyKazutaka Oda, Shinichiro Okamoto, Eisaku Iwanaga, et al.British Journal of Clinical Pharmacology|February 2, 2024
A simulation study on model-informed precision dosing of amikacin for achieving target area under the concentration-time curveTomoyuki Yamada, Kazutaka Oda, Masami Nishihara, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 21, 2024
Teicoplanin 24-h loading dose regimen using a decision tree model to target serum trough concentration of 15-30 μg/mL: A retrospective studyShoji Kondo, Kazutaka Oda, Tetsuya Kaneko, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 11, 2025
Role of continuous infusion in Bayesian-assisted vancomycin dosing guided by area under the concentration-time curve in adults: A scoping review with case seriesKazutaka Oda, Tomomi Katanoda, Shoji Kondo, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 24, 2020
Evaluation of once-daily dosing and target concentrations in therapeutic drug monitoring for arbekacin: A meta-analysisKazutaka Oda, Satoshi Fujii, Takehito Yamamoto, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2018
[Retrospective Analysis of Factors Decreasing the Efficacy of Tazobactam/Piperacillin for Pneumonia in Elderly Patients]Muramori So, Kazutaka Oda, Keiko Ota, et al.Clinical Therapeutics|April 29, 2023
Population Pharmacokinetics and AUC-Guided Dosing of Tobramycin in the Treatment of Infections Caused by Glucose-Nonfermenting Gram-Negative BacteriaYumi Hashiguchi, Naoya Matsumoto, Kazutaka Oda, et al.Therapeutic Drug Monitoring|November 26, 2013
Therapeutic drug monitoring based on early measurements of serum teicoplanin levels in Japanese patientsKazutaka Oda, Takashi Kasada, Masahiro Yoshikawa, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 24, 2020
Clinical evaluation of cefotiam in the treatment of bacteremia caused by Escherichia coli, Klebsiella species, and Proteus mirabilis: A retrospective studyYumi Hashiguchi, Kazutaka Oda, Tomomi Katanoda, et al.Pageof 6